{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:59:07Z","timestamp":1780750747239,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_28","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:00:54Z","timestamp":1753707654000},"page":"433-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Morpholino-Mediated Exon Inclusion for Spinal Muscular Atrophy (SMA)"],"prefix":"10.1007","author":[{"given":"Haiyan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"28_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/hmg\/7.7.1083","volume":"7","author":"MG Dunckley","year":"1998","unstructured":"Dunckley MG, Manoharan M, Villiet P, Eperon IC, Dickson G (1998) Modification of splicing in the dystrophin gene in cultured mdx muscle cells by antisense oligoribonucleotides. Hum Mol Genet 7:1083\u20131090","journal-title":"Hum Mol Genet"},{"key":"28_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165","journal-title":"Cell"},{"key":"28_CR3","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 96:6307\u20136311","journal-title":"Proc Natl Acad Sci USA"},{"key":"28_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR (2002) Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377\u2013384","journal-title":"Nat Genet"},{"key":"28_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","volume":"21","author":"PN Porensky","year":"2012","unstructured":"Porensky PN, Mitrpant C, McGovern VL, Bevan AK, Foust KD, Kaspar BK et al (2012) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet 21:1625\u20131638","journal-title":"Hum Mol Genet"},{"key":"28_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/hum.2012.211","volume":"24","author":"H Zhou","year":"2013","unstructured":"Zhou H, Janghra N, Mitrpant C, Dickinson R, Anthony K, Price L et al (2013) A novel Morpholino oligomer targeting ISS-N1 improves rescue of Severe SMA transgenic mice. Hum Gene Ther 24:331\u2013342","journal-title":"Hum Gene Ther"},{"key":"28_CR7","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1101\/gad.1941310","volume":"24","author":"Y Hua","year":"2010","unstructured":"Hua Y, Sahashi K, Hung G, Rigo F, Passini MA, Bennett CF et al (2010) Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev 24:1634\u20131644","journal-title":"Genes Dev"},{"key":"28_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature10485","volume":"478","author":"Y Hua","year":"2011","unstructured":"Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF et al (2011) Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478:123\u2013126","journal-title":"Nature"},{"key":"28_CR9","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1523\/JNEUROSCI.0950-09.2009","volume":"29","author":"JH Williams","year":"2009","unstructured":"Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK, Lutz GJ (2009) Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy. J Neurosci 29:7633\u20137638","journal-title":"J Neurosci"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.omtn.2017.02.009","volume":"7","author":"V Robin","year":"2017","unstructured":"Robin V, Griffith G, Carter JL, Leumann CJ, Garcia L, Goyenvalle A (2017) Efficient SMN rescue following subcutaneous Tricyclo-DNA antisense oligonucleotide treatment. Mol Ther Nucleic Acids 7:81\u201389","journal-title":"Mol Ther Nucleic Acids"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723\u20131732","journal-title":"N Engl J Med"},{"key":"28_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","volume":"378","author":"S Cirak","year":"2011","unstructured":"Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K et al (2011) Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378:595\u2013605","journal-title":"Lancet"},{"key":"28_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/1091581811403505","volume":"30","author":"P Sazani","year":"2011","unstructured":"Sazani P, Ness KP, Weller DL, Poage DW, Palyada K, Shrewsbury SB (2011) Repeat-dose toxicology evaluation in cynomolgus monkeys of AVI-4658, a phosphorodiamidate morpholino oligomer (PMO) drug for the treatment of duchenne muscular dystrophy. Int J Toxicol 30:313\u2013321","journal-title":"Int J Toxicol"},{"key":"28_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062114","volume":"8","author":"C Mitrpant","year":"2013","unstructured":"Mitrpant C, Porensky P, Zhou H, Price L, Muntoni F, Fletcher S et al (2013) Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. PLoS One 8:e62114","journal-title":"PLoS One"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clinthera.2014.02.004","volume":"36","author":"M Nizzardo","year":"2014","unstructured":"Nizzardo M, Simone C, Salani S, Ruepp MD, Rizzo F, Ruggieri M et al (2014) Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy Delta7 mouse model phenotype. Clin Ther 36:340\u2013356","journal-title":"Clin Ther"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1073\/pnas.1605731113","volume":"113","author":"SM Hammond","year":"2016","unstructured":"Hammond SM, Hazell G, Shabanpoor F, Saleh AF, Bowerman M, Sleigh JN et al (2016) Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy. Proc Natl Acad Sci USA 113:10962\u201310967","journal-title":"Proc Natl Acad Sci USA"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1093\/hmg\/ddu198","volume":"23","author":"EY Osman","year":"2014","unstructured":"Osman EY, Miller MR, Robbins KL, Lombardi AM, Atkinson AK, Brehm AJ et al (2014) Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models. Hum Mol Genet 23:4832\u20134845","journal-title":"Hum Mol Genet"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"20193","DOI":"10.1038\/srep20193","volume":"6","author":"EW Ottesen","year":"2016","unstructured":"Ottesen EW, Howell MD, Singh NN, Seo J, Whitley EM, Singh RN (2016) Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy. Sci Rep 6:20193","journal-title":"Sci Rep"},{"key":"28_CR19","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1093\/hmg\/ddu169","volume":"23","author":"KL Robbins","year":"2014","unstructured":"Robbins KL, Glascock JJ, Osman EY, Miller MR, Lorson CL (2014) Defining the therapeutic window in a severe animal model of spinal muscular atrophy. Hum Mol Genet 23:4559\u20134568","journal-title":"Hum Mol Genet"},{"key":"28_CR20","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1093\/hmg\/ddv329","volume":"24","author":"H Zhou","year":"2015","unstructured":"Zhou H, Meng J, Marrosu E, Janghra N, Morgan J, Muntoni F (2015) Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response. Hum Mol Genet 24:6265\u20136277","journal-title":"Hum Mol Genet"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:04:58Z","timestamp":1780747498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_28","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}